Brooks Laboratories Ltd

₹ 109 1.97%

26 Apr - close price

brookslabs.net BSE: 533543 NSE - BE : BROOKS

About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment^[1]

Key Points

Business Overview:^[1]
BLL is an EU GMP & ISO 9001:2008 certified manufacturer and marketer of pharmaceutical formulations

Website BSE NSE - BE

Market Cap ₹ 286 Cr.
Current Price ₹ 109
High / Low ₹ 186 / 56.5
Stock P/E 561
Book Value ₹ 26.2
Dividend Yield 0.00 %
ROCE -11.0 %
ROE -13.4 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter

Cons

Stock is trading at 4.16 times its book value
Company has low interest coverage ratio.
The company has delivered a poor sales growth of -0.06% over past five years.
Company has a low return on equity of -11.3% over last 3 years.
Debtor days have increased from 66.9 to 83.8 days.
Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	20.92	14.62	16.03	21.05	18.12	21.31	14.94	15.89	12.00	12.61	15.70	24.32	21.75
	21.57	18.30	14.54	19.86	19.72	20.98	18.98	16.16	13.47	12.73	15.67	22.60	20.66
Operating Profit	-0.65	-3.68	1.49	1.19	-1.60	0.33	-4.04	-0.27	-1.47	-0.12	0.03	1.72	1.09
OPM %	-3.11%	-25.17%	9.30%	5.65%	-8.83%	1.55%	-27.04%	-1.70%	-12.25%	-0.95%	0.19%	7.07%	5.01%
	0.04	0.31	0.47	0.34	0.22	0.37	0.05	0.07	0.06	0.02	0.05	0.09	0.16
Interest	0.78	0.74	0.18	0.12	0.13	0.23	0.16	0.19	0.24	0.18	0.17	0.19	0.21
Depreciation	1.72	1.69	0.36	0.35	0.36	0.42	0.42	0.43	0.43	0.44	0.44	0.44	0.43
Profit before tax	-3.11	-5.80	1.42	1.06	-1.87	0.05	-4.57	-0.82	-2.08	-0.72	-0.53	1.18	0.61
Tax %	0.00%	-123.28%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.92%
	-3.12	-12.95	1.42	1.06	-1.87	0.05	-4.57	-0.82	-2.08	-0.72	-0.53	1.18	0.58
EPS in Rs	-1.19	-4.94	0.54	0.40	-0.71	0.02	-1.74	-0.31	-0.79	-0.27	-0.20	0.45	0.22
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	55.96	80.11	85.27	85.21	80.01	57.54	55.71	55.03	69.69	76.66	76.97	55.54	74.38
	45.48	69.61	76.75	78.36	68.93	52.50	64.64	63.40	72.27	75.65	75.10	61.35	71.66
Operating Profit	10.48	10.50	8.52	6.85	11.08	5.04	-8.93	-8.37	-2.58	1.01	1.87	-5.81	2.72
OPM %	18.73%	13.11%	9.99%	8.04%	13.85%	8.76%	-16.03%	-15.21%	-3.70%	1.32%	2.43%	-10.46%	3.66%
	0.92	0.01	0.00	5.04	1.69	0.12	0.24	2.88	-0.94	0.90	0.95	0.11	0.32
Interest	1.56	0.11	0.12	0.44	0.79	1.01	2.40	2.96	3.35	3.25	0.67	0.77	0.75
Depreciation	0.66	0.81	0.83	1.10	1.16	1.67	6.45	6.50	6.65	7.09	1.49	1.72	1.75
Profit before tax	9.18	9.59	7.57	10.35	10.82	2.48	-17.54	-14.95	-13.52	-8.43	0.66	-8.19	0.54
Tax %	3.70%	25.44%	4.36%	8.50%	1.66%	33.06%	21.21%	0.94%	-80.33%	-84.82%	0.00%	0.00%
	8.84	7.14	7.24	9.47	10.63	1.67	-13.81	-14.81	-24.38	-15.59	0.67	-8.19	0.51
EPS in Rs	3.55	2.87	2.91	3.80	4.27	0.67	-5.55	-5.95	-9.31	-5.95	0.26	-3.13	0.20
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-4%
5 Years:	0%
3 Years:	-7%
TTM:	16%

Compounded Profit Growth
10 Years:	%
5 Years:	7%
3 Years:	18%
TTM:	107%

Stock Price CAGR
10 Years:	20%
5 Years:	20%
3 Years:	8%
1 Year:	73%

Return on Equity
10 Years:	-5%
5 Years:	-15%
3 Years:	-11%
Last Year:	-13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	16.19	16.19	16.19	16.19	16.19	16.19	16.19	16.19	24.70	24.70	24.70	24.70	26.25
Reserves	75.08	89.22	96.10	95.23	105.86	112.09	98.29	88.96	73.71	39.51	40.30	32.08	42.45
	0.99	1.09	0.14	0.51	5.71	13.72	27.98	31.18	27.64	8.40	5.97	6.51	4.21
	14.51	25.16	20.04	23.61	24.77	22.13	30.21	31.55	31.81	20.39	32.48	29.13	22.66
Total Liabilities	106.77	131.66	132.47	135.54	152.53	164.13	172.67	167.88	157.86	93.00	103.45	92.42	95.57
	22.13	20.65	20.15	15.68	16.34	125.95	124.64	117.70	113.02	14.96	15.14	15.01	14.21
CWIP	33.88	35.52	37.16	52.86	86.86	0.00	0.52	0.29	0.11	0.02	1.12	0.00	0.00
Investments	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	46.81	46.84	46.85	47.80
	50.74	75.47	75.14	66.98	49.31	38.16	47.49	49.87	44.71	31.21	40.35	30.56	33.56
Total Assets	106.77	131.66	132.47	135.54	152.53	164.13	172.67	167.88	157.86	93.00	103.45	92.42	95.57

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	-0.82	5.39	10.65	2.13	8.12	9.56	-6.18	-5.05	-9.39	-0.90	3.12	0.56
	-41.02	-1.31	-10.64	-1.12	-13.56	-16.80	-5.14	1.12	-2.33	-0.74	1.12	-0.40
	60.61	0.15	0.29	-0.07	4.32	7.01	11.82	5.78	9.61	1.31	-4.23	-0.22
Net Cash Flow	18.77	4.23	0.30	0.94	-1.12	-0.23	0.51	1.85	-2.10	-0.33	0.02	-0.06

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	70.18	98.78	70.46	82.63	86.27	67.81	66.70	75.75	81.50	45.66	71.27	83.79
Inventory Days	51.64	31.69	37.59	45.32	46.12	75.53	103.93	93.03	107.30	91.81	119.53	99.41
Days Payable	72.46	81.78	99.87	114.65	108.29	180.19	242.76	251.23	203.15	99.30	185.53	205.59
Cash Conversion Cycle	49.37	48.69	8.18	13.30	24.09	-36.85	-72.12	-82.45	-14.35	38.17	5.28	-22.39
Working Capital Days	59.35	85.57	29.45	43.82	23.13	-13.00	-20.97	-29.85	17.96	27.76	26.65	-3.81
ROCE %	17.85%	9.76%	7.03%	7.24%	9.58%	2.59%	-10.64%	-8.72%	-6.72%	-5.15%	1.49%	-11.05%

Shareholding Pattern

Numbers in percentages

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	66.41%	66.41%	66.41%	66.41%	66.41%	66.41%	66.41%	66.41%	66.41%	63.59%	63.59%	63.59%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.46%	3.86%	3.86%
	33.59%	33.59%	33.59%	33.59%	33.59%	33.58%	33.59%	33.59%	33.58%	33.94%	32.56%	32.55%
No. of Shareholders	10,429	10,379	10,916	11,145	11,104	10,524	10,410	10,709	11,216	10,686	10,028	11,432

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	60.62%	60.62%	60.62%	66.41%	66.41%	66.41%	66.41%	63.59%
	0.24%	0.14%	0.01%	0.00%	0.00%	0.00%	0.00%	3.86%
	39.14%	39.24%	39.37%	33.58%	33.59%	33.59%	33.59%	32.55%
No. of Shareholders	10,749	11,548	11,826	11,589	10,702	11,145	10,709	11,432

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Brooks Laboratories Ltd

Brooks Laboratories Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings